#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Ovarian cancer Colorectal cancer Hepatocellular carcinoma Asthma Dermatitis atopic Dementia Alzheimer's type Type 2 diabetes mellitus Breast cancer metastatic Non-small cell lung cancer metastatic More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    High-grade B-cell lymphoma Vitamin B12 deficiency Sarcoma Demyelination Chondrosarcoma Malignant neoplasm of choroid Non-small cell lung cancer Familial haemophagocytic lymphohistiocytosis Gaucher's disease type I Alagille syndrome Pyoderma gangrenosum Bulbospinal muscular atrophy congenital Osteogenesis imperfecta Acute graft versus host disease Essential thrombocythaemia More trials…

    Learn about Rare Diseases

    Loeys-Dietz syndrome – Treatment Alveolar rhabdomyosarcoma – Treatment Mast cell activation syndrome – Basic Information Behcet’s syndrome – Life with Disease Hepatic angiosarcoma Hyperoxaluria – Life with Disease Proteus syndrome – Basic Information Netherton’s syndrome – Life with Disease Leiomyosarcoma metastatic Andersen-Tawil syndrome More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Exl01 Timrepigene Emparvovec Trimetazidine Dihydrochloride Abc-24F-116 68Ga-Nota-Abscint-Her2 Bupivacaine Hydrochloride ALLO-QUADCAR01-T Melatonin Ciprofloxacin Inebilizumab Cinnarizine Fluorouracil Midomafetamine Hydrochloride TIL CELLS Axicabtagene Ciloleucel Fenofibrate Micronised Romosozumab Raludotatug Deruxtecan DUVELISIB Lorlatinib More therapies…

    Learn about Your Condition

    Noonan syndrome Coronary artery disease Stomatitis Colon cancer stage II HER2 negative breast cancer Stevens-Johnson syndrome Catatonia Endometrial cancer recurrent Agitation Gouty arthritis Schizoaffective disorder Critical illness Eyelid ptosis Cardiomyopathy Clinically isolated syndrome More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. Somogy Varmegyei Kaposi Mor Oktato Korhaz

Somogy Varmegyei Kaposi Mor Oktato Korhaz

Tallian Gyula Utca 20-32, Kaposvar, 7400, Hungary

Want to learn more about this study or check if you can participate? Contact us.

  • Study Comparing Elranatamab and Lenalidomide for Patients with Newly Diagnosed Multiple Myeloma After Stem-Cell Transplantation

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Plasma cell myeloma
    Investigated Drugs:
    • Elranatamab
    • Human Normal Immunoglobulin
    • Lenalidomide
    Austria Belgium Czechia Finland France Germany +8

  • Study on the Effects of Ponsegromab on Quality of Life and Safety in Adults with Heart Failure

    Not recruiting

    2 1
    Investigated Drugs:
    • Ponsegromab
    Czechia Germany Hungary Poland Spain

  • Study on the Effectiveness and Safety of Finerenone for Adults with Non-Diabetic Chronic Kidney Disease

    Not recruiting

    3 1
    Investigated Diseases:
    • Chronic kidney disease
    Investigated Drugs:
    • Finerenone
    Belgium Bulgaria Czechia Denmark Greece Hungary +3

  • Study Comparing Fedratinib with Drug Combination for Myelofibrosis in Patients Previously Treated with Ruxolitinib

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Myelofibrosis
    Investigated Drugs:
    • Busulfan
    • Danazol
    • Dimethyl Fumarate
    Austria Belgium Czechia France Germany Hungary +4

  • Study on the Safety of Starting Vericiguat at 5 mg in Patients with Chronic Heart Failure with Reduced Ejection Fraction

    Not recruiting

    2 1 1
    Investigated Drugs:
    • Vericiguat
    Hungary Italy Poland Spain Sweden

  • Study Comparing Asciminib with Other Drug Combinations for Adults with Newly Diagnosed Chronic Myeloid Leukemia

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Chronic myeloid leukaemia
    Investigated Drugs:
    • Bosutinib
    • Imatinib
    • Asciminib Hydrochloride
    Austria Belgium Bulgaria Czechia Denmark Finland +9

  • Study Comparing Subcutaneous and Intravenous Isatuximab with Pomalidomide and Dexamethasone for Adults with Relapsed or Refractory Multiple Myeloma

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Plasma cell myeloma recurrent
    Investigated Drugs:
    • Isatuximab
    • Montelukast Sodium
    • Dexamethasone
    Czechia France Germany Greece Hungary Italy +4

  • Study on the Safety and Effectiveness of Tovinontrine for Adults with Chronic Heart Failure with Reduced Ejection Fraction

    Not recruiting

    2 1
    Investigated Drugs:
    • Tovinontrine
    Belgium Bulgaria Czechia Germany Hungary Italy +6

  • Study on the Safety and Effectiveness of Betula Pollen Extract for Children and Adolescents Aged 5-17 with Birch Pollen Allergies and Possible Asthma

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Conjunctivitis allergic
    Investigated Drugs:
    • Betula Pollen Extract
    Austria Bulgaria Finland France Germany Hungary +6

  • Study on REGN7508 for Preventing Blood Clots in Adults After Knee Replacement Surgery

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    • Embolism
    Investigated Drugs:
    • Enoxaparin Sodium
    • Regn7508
    Bulgaria Hungary Latvia Lithuania Poland
Previous Page
1 … 6 7 8 9 10 … 12
Next Page

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!